Alpha-synuclein is a major component of Lewy bodies in Parkinson's disease and is found associated with several other forms of dementia. As with other neurodegenerative diseases, the ability of alpha-synuclein to aggregate and form fibrillar deposits seems central to its pathology. We have defined a sequence within the NAC region of alpha-synuclein that is necessary for aggregation. Exploitation of chemically modified analogues of this peptide may produce inhibitors of aggregation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2174/0929866043407084 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!